Metropolitan Life Insurance Company (MetLife)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,460
| Closed | -$120K | – | 2606 |
|
|
2020
Q4 | $120K | Hold |
9,460
| – | – | ﹤0.01% | 2262 |
|
|
2020
Q3 | $92.9K | Hold |
9,460
| – | – | ﹤0.01% | 2257 |
|
|
2020
Q2 | $94.1K | Hold |
9,460
| – | – | ﹤0.01% | 2289 |
|
|
2020
Q1 | $83.6K | Buy |
+9,460
| New | +$83.6K | ﹤0.01% | 2144 |
|
|
2019
Q4 | – | Sell |
-7,553
| Closed | -$44.4K | – | 2577 |
|
|
2019
Q3 | $44.4K | Hold |
7,553
| – | – | ﹤0.01% | 2508 |
|
|
2019
Q2 | $90.6K | Hold |
7,553
| – | – | ﹤0.01% | 2356 |
|
|
2019
Q1 | $91.2K | Hold |
7,553
| – | – | ﹤0.01% | 2364 |
|
|
2018
Q4 | $94.8K | Buy |
7,553
+1,205
| +19% | +$15.1K | ﹤0.01% | 2312 |
|
|
2018
Q3 | $94.2K | Hold |
6,348
| – | – | ﹤0.01% | 2483 |
|
|
2018
Q2 | $107K | Hold |
6,348
| – | – | ﹤0.01% | 2284 |
|
|
2018
Q1 | $145K | Hold |
6,348
| – | – | ﹤0.01% | 2089 |
|
|
2017
Q4 | $164K | Buy |
+6,348
| New | +$164K | ﹤0.01% | 2021 |
|
|
2017
Q3 | – | Sell |
-12,976
| Closed | -$181K | – | 2545 |
|
|
2017
Q2 | $181K | Buy |
+12,976
| New | +$181K | ﹤0.01% | 2397 |
|
|
2016
Q3 | – | Sell |
-11,833
| Closed | -$133K | – | 2656 |
|
|
2016
Q2 | $133K | Hold |
11,833
| – | – | ﹤0.01% | 2567 |
|
|
2016
Q1 | $162K | Hold |
11,833
| – | – | ﹤0.01% | 2291 |
|
|
2015
Q4 | $224K | Hold |
11,833
| – | – | ﹤0.01% | 2180 |
|
|
2015
Q3 | $222K | Hold |
11,833
| – | – | ﹤0.01% | 2220 |
|
|
2015
Q2 | $176K | Buy |
+11,833
| New | +$176K | ﹤0.01% | 2478 |
|